Valuation check: NSTG's profit margin is -102.44%, below the Healthcare sector average of 13.89%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2023
Trailing 12 months ending Sep 2023
The latest profit margin for NSTG is -102.44% as of September 2023. That compares with -106.94% in the prior-year period — up 4.2% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Nanostring Technologies's historical trend and sector peers before judging valuation or financial health.
Over the past year, NSTG's profit margin moved from -106.94% to -102.44% — a 4.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Nanostring Technologies's valuation or profitability profile.
Against Healthcare companies, NSTG currently prints -102.44% for profit margin, while the sector average sits near 13.89%. That is roughly 837.7% below the sector mean. Large gaps often invite a closer look at Nanostring Technologies's growth, margins, and balance sheet.
Profit Margin shows how effectively Nanostring Technologies converts resources into returns. At -102.44%, NSTG may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -106.94% in the prior-year period — up 4.2% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting NSTG's profit margin (-102.44%), review year-over-year change from -106.94%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.